Please wait while the formulary information is being retrieved.
BROMFED DM (brompheniramine maleate/pseudoephedrine HCl/dextromethorphan)
- cold symptoms
- cough
- inflammation of the nose due to an allergy
- runny nose
- stuffy nose
- vasomotor rhinitis
- Brompheniramine-pseudoephedrine-dm Syrup
- Brompheniramine-pseudoephedrine-dm Oral Syrup
- Bromfed Dm Oral Syrup
- By Indication
brompheniramine-pseudoephedrine-DM 2 mg-30 mg-10 mg/5 mL oral syrup
- 10 milliliters by oral route every 4 hours
brompheniramine-pseudoephedrine-DM 2 mg-30 mg-10 mg/5 mL oral syrup
- 10 milliliters by oral route every 4 hours
2 mg-30 mg-10 mg/5 mL oral syrup
- 10 milliliters by oral route every 4 hours
Default screening record
- 10 milliliters by oral route every 4 hours
- Azilect
- Eldepryl
- isocarboxazid
- linezolid
- Marplan
- Matulane
- methylene blue (antidote)
- Nardil
- Parnate
- phenelzine
- procarbazine
- rasagiline
- selegiline HCl
- tranylcypromine
- Zelapar
- Zyvox
Contraindicated
- bromocriptine
- cabergoline
- Cafergot
- Cycloset
- D.h.e.45
- dihydroergotamine
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- K-tab
- Klor-con
- Klor-con 10
- Klor-con M10
- Klor-con M15
- Klor-con M20
- Medi-lyte
- methylergonovine
- Migergot
- Migranal
- Parlodel
- potassium chloride
- potassium citrate
- potassium Cl-calcium phos-mag
- sodium Cl-potassium chloride
- Thermotabs
- Urocit-k 10
- Urocit-k 15
- Urocit-k 5
Severe
Moderate
- methyldopa
- methyldopa-hydrochlorothiazide
- methyldopate
- reserpine
- Severe coronary artery disease
- Severe uncontrolled hypertension
- Urinary retention
Contraindicated
- Angle-closure glaucoma
- Benign prostatic hyperplasia
- Bladder outflow obstruction
- Chronic idiopathic constipation
- Diabetes mellitus
- Hypertension
- Hyperthyroidism
- Stenosing peptic ulcer
- Systemic mastocytosis
- Urinary retention
Severe
Moderate
- Hypertension
- Hyperthyroidism
- Ocular hypertension
BROMFED DM (brompheniramine maleate/pseudoephedrine HCl/dextromethorphan)
- cold symptoms
- cough
- inflammation of the nose due to an allergy
- runny nose
- stuffy nose
- vasomotor rhinitis
- None
- Anticholinergic toxicity
- Dizziness
- Drowsy
- Headache disorder
- Insomnia
- Thick bronchial secretions
More Frequent
Severe
Less Severe
- None
- Agitation
- Anorexia
- Dizziness
- Drowsy
- Dysuria
- General weakness
- Muscle weakness
- Nausea
- Nervousness
- Pallor
- Sedation
- Tachycardia
- Tremor
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute generalized exanthematous pustulosis
- Anaphylaxis
- Blood dyscrasias
- Dyspnea
- Extrasystoles
- Hallucinations
- Hemolytic anemia
- Hypersensitivity drug reaction
- Hypertension
- Hypotension
- Ischemic colitis
- Seizure disorder
- Vomiting
Less Severe
- Abdominal distension
- Abdominal pain with cramps
- Accidental fall
- Acute abdominal pain
- Acute cognitive impairment
- Agitation
- Anorexia
- Anticholinergic toxicity
- Ataxia
- Blurred vision
- Cardiac arrhythmia
- Chest discomfort
- Chills
- Constipation
- Diarrhea
- Diplopia
- Dizziness
- Drowsy
- Dry nose
- Dry throat
- Dyspepsia
- Dyspnea
- Dysuria
- Euphoria
- Excitement
- Fatigue
- Headache disorder
- Hyperhidrosis
- Insomnia
- Irritability
- Maculopapular rash
- Malaise
- Migraine
- Nausea
- Nervousness
- Nightmares
- Palpitations
- Paresthesia
- Pruritus of skin
- Skin photosensitivity
- Skin rash
- Symptoms of anxiety
- Tachycardia
- Tinnitus
- Tremor
- Urinary retention
- Urticaria
- Vertigo
- Visual changes
- Vomiting
- Wheezing
- Xerostomia
Contraindicated
D-methorphan_Pseudoephedrine_BPM
Infants and small children at increased risk of CNS adverse events, seizure, hallucination, decreased alertness. Should not use with underlying asthma. Alternate methods suggested for treating cough and cold symptoms in this age group.
- 1 Day – 2 Years
- 1 Infants and small children at increased risk of CNS adverse events, seizure, hallucination, decreased alertness. Should not use with underlying asthma. Alternate methods suggested for treating cough and cold symptoms in this age group.
Severe Precaution
D-methorphan_Pseudoephedrine_BPM
Use of OTC formulation requires clinician consultation for age <6 years. Risk of adverse CNS effects, decreased alertness, paradoxical excitation. Do not use with asthma.
- 2 Years – 6 Years
- Use of OTC formulation requires clinician consultation for age <6 years. Risk of adverse CNS effects, decreased alertness, paradoxical excitation. Do not use with asthma.
Management or Monitoring Precaution
None
Brompheniramine
- Severity Level:
2
- Additional Notes: Low risk, premature infant at risk of retrolental fibroplasia
Dextromethorphan
- Severity Level:
2
- Additional Notes: Available human data show no increased risk for major birth defects
Pseudoephedrine
- Severity Level:
2
- Additional Notes: Limited human data are inconclusive on developmental toxicity risk
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Brompheniramine
Not recommended. may cause paradoxical excitation/inhibit lactation.
Insufficient data available; molecular wt low enough for possible excretion
May decrease milk supply and cause irritability
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Not recommended. may cause paradoxical excitation/inhibit lactation. |
Dextromethorphan
Not recommended. may cause paradoxical excitation/inhibit lactation.
Insufficient data available; molecular wt low enough for possible excretion
May decrease milk supply and cause irritability
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available; molecular wt low enough for possible excretion |
Pseudoephedrine
Not recommended. may cause paradoxical excitation/inhibit lactation.
Insufficient data available; molecular wt low enough for possible excretion
May decrease milk supply and cause irritability
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Drug shown to have adverse effect | May decrease milk supply and cause irritability |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Brompheniramine
Neuro/Psych-Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Non-sedating agents preferred. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.
Cardiovascular-Elderly are more sensitive to tachycardia and hypertensive effects. May exacerbate symptomatic coronary insufficiency. Genitourinary-May cause urinary retention. Neuro/Psych-May worsen cognitive impairment in some elderly with dementia. Insomnia risk.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | N | Y | Y | N | N |
BEERS: Y HEDIS: Y STOPP: Y
Pseudoephedrine
Neuro/Psych-Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Non-sedating agents preferred. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.
Cardiovascular-Elderly are more sensitive to tachycardia and hypertensive effects. May exacerbate symptomatic coronary insufficiency. Genitourinary-May cause urinary retention. Neuro/Psych-May worsen cognitive impairment in some elderly with dementia. Insomnia risk.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | Y | Y | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Allergic rhinitis | |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| J30.5 | Allergic rhinitis due to food |
| J30.8 | Other allergic rhinitis |
| J30.81 | Allergic rhinitis due to animal (cat) (dog) hair and dander |
| J30.89 | Other allergic rhinitis |
| J30.9 | Allergic rhinitis, unspecified |
| Cold symptoms | |
| J00 | Acute nasopharyngitis [common cold] |
| Cough | |
| R05 | Cough |
| R05.1 | Acute cough |
| R05.2 | Subacute cough |
| R05.3 | Chronic cough |
| R05.9 | Cough, unspecified |
| Nasal congestion | |
| R09.81 | Nasal congestion |
| Rhinorrhea | |
| R09.82 | Postnasal drip |
| Vasomotor rhinitis | |
| J30.0 | Vasomotor rhinitis |
| 0-9 | A-Z |
|---|---|
| J00 | Acute nasopharyngitis [common cold] |
| J30.0 | Vasomotor rhinitis |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| J30.5 | Allergic rhinitis due to food |
| J30.8 | Other allergic rhinitis |
| J30.81 | Allergic rhinitis due to animal (cat) (dog) hair and dander |
| J30.89 | Other allergic rhinitis |
| J30.9 | Allergic rhinitis, unspecified |
| R05 | Cough |
| R05.1 | Acute cough |
| R05.2 | Subacute cough |
| R05.3 | Chronic cough |
| R05.9 | Cough, unspecified |
| R09.81 | Nasal congestion |
| R09.82 | Postnasal drip |
Formulary Reference Tool